DJ-1 protein levels can be measured in the CSF, particularly during the early stages of the disease, highlighting its potential utility as a biomarker for early PD detection and as a therapeutic target aimed at reducing neuroinflammation and promoting neuronal survival [5,49]. The gene discussed is PARK7; the disease is Parkinson disease.